• Publications
  • Influence
Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis
TLDR
HAI gemcitabine and FUDR is effective to improve DCR of intrahepatic lesions and prolong mOS for patients with nasopharyngeal carcinoma liver metastases, and is associated with a relative low rate of toxicity.
Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
TLDR
It is reported that the existence of remnant tumor masses due to incomplete RFA (iRFA) is associated with earlier new metastases and poor survival in patients with colorectal cancer liver metastases (CRCLM), and it is demonstrated that iRFA promotes tumor progression and hinders the efficacy of anti-PD-1 therapy.
Catheter‐Based Computed Tomography Angiography in Anterolateral Thigh Perforator Mapping of Chinese Patients
TLDR
C‐CTA outperforms T‐ CTA in the preoperative perforator mapping of ALT flaps in a subgroup of Chinese limb trauma patients with limited activity and should be the method of choice for perforATOR mapping in patients whose ALT perforators are intended for extremity reconstruction.
Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
TLDR
TRIM52-AS1 sponged miR-514a-5p to facilitate HCC progression through increasing MRPS18A expression and was revealed to be upregulated in HCC tissue samples according to GEPIA database.
Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in Two Centers
TLDR
Subgroup analysis revealed that patients without EHM, with higher intrahepatic tumor burden and with synchronous liver metastasis benefited more from HAI, and first-line treatment with HAI FUDR plus SCT resulted in higher intraHepatic response and better OS.
A Predictive Scoring Model for Short-Term Local Recurrent Nasopharyngeal Carcinoma Based on Magnetic Resonance Imaging.
TLDR
Residual lesions in NC, MSI, SBBE, and MDCNI are independent risk factors in predicting the short-term recurrence of NPC, and the authors' findings suggest that patients with a score of more than 10.50 points should be hypervigilant regarding the possibility of short- term recurrence.
Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy
TLDR
The CT-based estimations of myosteatosis could be used as an indicator to predict a higher risk of transition to the Non-OR disease state in HCC patients treated with immune-HAIC therapy.